Fundraising Fox
(주)지엘팜텍
Seongnam, KR · 2 known investors
Find your way into (주)지엘팜텍
Sign up to see every warm intro you have to (주)지엘팜텍
- Paths you didn't know you had: your email and LinkedIn already hold routes to the (주)지엘팜텍 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GLPharmTech (지엘팜텍) develops incrementally modified drugs, including pregabalin extended-release tablets for neuropathic pain such as diabetic peripheral neuropathy and postherpetic neuralgia. The company is a South Korean pharmaceutical firm producing prescription central nervous system medications.
Founders & leadership
JS
Jin Seong-pilCo-CEO
KY
Kim Yong-ilCo-CEO
진
진성필
김
김용일
Investors · 2
Frequently asked questions
- What does (주)지엘팜텍 do?
- GLPharmTech (지엘팜텍) develops incrementally modified drugs, including pregabalin extended-release tablets for neuropathic pain such as diabetic peripheral neuropathy and postherpetic neuralgia. The company is a South Korean pharmaceutical firm producing prescription central nervous system medications.
- Who are (주)지엘팜텍's investors?
- (주)지엘팜텍's investors include Magna Investment, SBI Investment Korea Co. Ltd..
- Where is (주)지엘팜텍 headquartered?
- (주)지엘팜텍 is headquartered in Seongnam, KR.